Page last updated: 2024-11-09

nap taurine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

NAP taurine: photochemical labelling reagent for erythrocyte membrane; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID2735434
MeSH IDM0056719

Synonyms (10)

Synonym
nsc-328388
nap taurine
ep7t8v37cs ,
unii-ep7t8v37cs
57462-29-0
ethanesulfonic acid, 2-((4-azido-2-nitrophenyl)amino)-
n-(4-azido-2-nitrophenyl)-2-aminoethylsulfonate
n-(4-azido-2-nitro-phenyl)-2-aminoethyl sulfonic acid
2-(4-azido-2-nitroanilino)ethane-1-sulfonic acid
DTXSID30972948

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" In addition, there is a close relationship between the dose-response curves for 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid inhibition of VA taurine efflux and sulfate efflux."( Volume-activated taurine efflux from skate erythrocytes: possible band 3 involvement.
Brill, SR; Goldstein, L, 1991
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (27)

TimeframeStudies, This Drug (%)All Drugs %
pre-199023 (85.19)18.7374
1990's3 (11.11)18.2507
2000's0 (0.00)29.6817
2010's1 (3.70)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.66 (24.57)
Research Supply Index3.33 (2.92)
Research Growth Index3.99 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.70%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other26 (96.30%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]